TIFFANY HOCHET: Open Payments
NPI 1023422649 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 18 payments from 11 companies in 2025. Trend: 2023 $730 · 2024 $617 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $139 |
| Corcept Therapeutics | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Novo Nordisk Inc | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Amgen Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: FARXIGA, Korlym, LEQVIO, JARDIANCE, INJECTAFER, VRAYLAR, Veozah, OTEZLA.
Industry payments across SC — which companies pay providers there.
